What is three-person IVF and who might consider it
Three-person IVF, sometimes called mitochondrial donation or spindle transfer, is an assisted reproductive technique designed to reduce the risk of passing on certain mitochondrial diseases by combining genetic material from three individuals. It involves replacing mutated mitochondrial DNA in an intended mother’s egg with healthy mitochondrial DNA from a donor egg, while keeping the intended parents’ nuclear DNA. This overview explains the biological basis, how the procedure is performed, and which families may be candidates, including those with a known mitochondrial disorder or those who have had repeated IVF failure due to oocyte mitochondrial dysfunction.
How three-person IVF works: key steps and biological rationale
Three-person IVF typically follows these major phases: ovarian stimulation, egg retrieval, mitochondrial transfer, fertilization and embryo culture, and embryo transfer. The central biological step is replacing defective mitochondria with donor mitochondria so that early embryos receive energy-producing organelles capable of supporting development. This section outlines each phase in more detail, explains spindle transfer and pronuclear transfer as technical variants, and discusses how timing and laboratory conditions influence outcomes.
Spindle transfer workflow
- Ovarian stimulation and monitoring to optimize egg yield and quality.
- Retrieval of the intended mother’s egg and a donor egg matched for blood type and Rh status.
- Removal of the spindle-chromosome complex from the intended mother’s egg and insertion into the enucleated donor egg.
- Fusion or direct injection to create an embryo with the intended mother’s nuclear DNA and donor mitochondrial DNA.
- Culture to the blastocyst stage, genetic testing if indicated, and transfer to the uterus.
Pronuclear transfer variant
Pronuclear transfer occurs shortly after fertilization, before the parental pronuclei fuse. Both the zygote from the intended parents and a donor zygote are enucleated, and the parental pronuclei are transferred into the enucleated donor embryo. This allows the resulting embryo to retain the parents’ nuclear DNA while receiving functional mitochondria. Variations such as maternal spindle transfer and polar body transfer exist, each with distinct biological trade-offs and technical requirements.
Eligibility criteria and ideal candidates
Candidates for three-person IVF are generally restricted to those at substantial risk of mitochondrial disease or those who have exhausted other standard IVF options where mitochondrial dysfunction may be a factor. Eligibility often requires specialist referral, documented mitochondrial abnormalities, or prior poor embryo quality suggestive of mitochondrial compromise.
Common eligibility criteria
- Known pathogenic or likely pathogenic mutations in mitochondrial DNA.
- Multiple IVF failures or repeated early pregnancy loss where mitochondrial factors are suspected.
- Age-related decline in oocyte mitochondrial function contributing to poor embryo development.
- Availability of a healthy mitochondrial donor and informed consent from both intended parents.
Success rates and what to expect in terms of pregnancy outcomes
Success with three-person IVF varies by program, patient age, and underlying indication. While live birth rates per transfer are generally comparable to conventional IVF for selected patients, cumulative success depends heavily on egg quality, embryo culture, and prior reproductive history. Clinics offering mitochondrial donation often report respectable ongoing pregnancy rates, though outcomes should be interpreted cautiously given variable definitions and follow-up duration.
| Metric | Typical range or estimate | Context and notes |
|---|---|---|
| Live birth rate per embryo transfer | 30–45% in experienced programs | Comparable to age-matched standard IVF when eligibility criteria are applied. |
| Cumulative live birth rate after 3 transfers | 50–65% | Depends on embryo availability, endometrial receptivity, and patient age. |
| Ongoing pregnancy rate for mitochondrial disease prevention | Variable; reports of healthy births with undetectable mutant mtDNA | Success depends on the level of mutant mtDNA and strict donor selection. |
| Average total cost per cycle | $20,000–$30,000 in specialized centers | May include donor compensation, genetic testing, and extended culture. |
Potential risks, limitations, and safety considerations
Three-person IVF involves known IVF risks such as ovarian hyperstimulation syndrome, multiple pregnancy, and procedural discomfort, plus unique considerations related to mitochondrial donation. Cytoplasmic interactions between donor mitochondria and the intended mother’s nuclear genome may influence development, and long-term follow-up data are still accumulating. Although most reported births appear healthy, clinics are encouraged to report outcomes and participate in registries to monitor late effects.
Legal, ethical, and logistical considerations
Regulation of mitochondrial donation varies by country and jurisdiction, with some regions allowing carefully supervised clinical use and others restricting or prohibiting it on ethical grounds. Issues include donor anonymity, long-term follow-up responsibilities, and the societal implications of germline modification. Intended parents should review local laws, understand counseling requirements, and plan for any necessary legal steps such as parental recognition or adoption proceedings where applicable.
Next steps if you are considering three-person IVF
If you are exploring three-person IVF, start with a comprehensive fertility and genetic counseling appointment to assess your specific risk of mitochondrial disease and overall reproductive options. Bring prior medical records, genetic test results, and a clear list of questions about clinic experience, success metrics, and costs. Discuss follow-up plans, registry participation, and long-term monitoring so you can make an informed, values-aligned decision.